Changes in circulating immune biomarkers following nivolumab with or without ipilimumab for metastatic anal cancer (NCI9673).
Year: 2024
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Van K. Morris, Joshua Ochieng, Kristen Keon Ciombor, Blase N. Polite, Sarbajit Mukherjee, John C. Krauss, Anthony F. Shields, Olivia Aranha, John L. Hays, Syed Mohammad Ali Kazmi, Benjamin Adam Weinberg, Al B. Benson, Christopher Hanyoung Lieu, Syma Iqbal, Howard S. Hochster, Lianchun Xiao, Cara L. Haymaker, Cathy Eng
Institutions: The University of Texas MD Anderson Cancer Center, Vanderbilt University, Vanderbilt-Ingram Cancer Center, University of Chicago Medical Center, Roswell Park Comprehensive Cancer Center, University of Michigan, The Barbara Ann Karmanos Cancer Institute, Washington University in St. Louis, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The University of Texas Southwestern Medical Center, MedStar Georgetown University Hospital, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, University of Colorado Cancer Center, USC Norris Comprehensive Cancer Center, Rutgers Cancer Institute
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4391095603